Clinical Trial Update: Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial update of Zarnestra (tipifarnib) in combination with Gleevec (imatinib) for chronic-phase chronic myeloid leukemia. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• ZARNESTRA

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myeloid, Chronic | Phase 1 | Status: COMPLETED